Literature DB >> 5666116

Control of phosphate excretion in uremic man.

E Slatopolsky, A M Robson, I Elkan, N S Bricker.   

Abstract

The present studies were performed in an effort to examine the characteristics of the control system governing phosphate excretion in uremic man. In a group of patients with glomerular filtration rates (GFR) ranging from normal to 2 ml/min, it was found that the lower the GFR the lower the fraction of filtered phosphate reabsorbed (TRP). On a fixed phosphate intake, phosphate excretion rate was the same in patients with GFRs ranging from 60 to 3 ml/min. When plasma phosphate concentrations were diminished to subnormal levels in hyperphosphatemic, hypocalcemic uremic patients, TRP values increased but did not return to normal. TRP failed to rise substantially when GFR, as well as plasma phosphate concentrations, were diminished. In patients with unilateral renal disease, TRP values were equal bilaterally, and values were substantially higher in the diseased kidneys than in patients with bilateral involvement. When plasma calcium concentrations were raised to normal for 2-3 wk in uremic patients in whom plasma phosphate concentrations had previously been lowered to subnormal levels, TRP values rose to an average value of 86%. Values remained in the normal range when phosphate concentrations were allowed to increase while normocalcemia was maintained. The data are interpreted to indicate that in advancing renal disease, the changing patterns of phosphate excretion are mediated by a control system in which parathyroid hormone serves as a major effector element. An increase in GFR per nephron, hyperphosphatemia, and intrinsic inability of the surviving nephrons to transport phosphate do not appear to be of primary importance in the progressive reduction in TRP.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5666116      PMCID: PMC297347          DOI: 10.1172/JCI105877

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  BONE DISEASE IN CHRONIC RENAL FAILURE.

Authors:  R F FLETCHER; J H JONES; D B MORGAN
Journal:  Q J Med       Date:  1963-10

2.  PRODUCTION, EXCRETION, AND NET BALANCE OF FIXED ACID IN PATIENTS WITH RENAL ACIDOSIS.

Authors:  A D GOODMAN; J LEMANN; E J LENNON; A S RELMAN
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

3.  The treatment of renal-glomerular osteodystrophy.

Authors:  C E DENT; C M HARPER; G R PHILPOT
Journal:  Q J Med       Date:  1961-01

4.  Azotaemic renal osteodystrophy.

Authors:  S W STANBURY
Journal:  Br Med Bull       Date:  1957-01       Impact factor: 4.291

5.  Phosphorus excretion in renal failure.

Authors:  R GOLDMAN; S H BASSETT
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

6.  Radioimmunoassays of peptide hormones in plasma.

Authors:  S A Berson; R S Yalow
Journal:  N Engl J Med       Date:  1967-09-21       Impact factor: 91.245

7.  Hormonal control of hypercalcemia. Historic development of the calcitonin concept.

Authors:  D H Copp
Journal:  Am J Med       Date:  1967-11       Impact factor: 4.965

8.  The control of phosphate excretion in uremia.

Authors:  E Slatopolsky; L Gradowska; C Kashemsant; R Keltner; C Manley; N S Bricker
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

9.  The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis.

Authors:  J Lemann; J R Litzow; E J Lennon
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

10.  The influence of the parathyroid glands on the hypercalcemia of experimental magnesium depletion in the rat.

Authors:  H J Gitelman; S Kukolj; L G Welt
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

View more
  39 in total

Review 1.  Hyperphosphataemia in renal failure: causes, consequences and current management.

Authors:  Fouad Albaaj; Alastair Hutchison
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.

Authors:  Yu Ah Hong; Ji Hee Lim; Min Young Kim; Yaeni Kim; Keun Suk Yang; Byung Ha Chung; Sungjin Chung; Bum Soon Choi; Chul Woo Yang; Yong-Soo Kim; Yoon Sik Chang; Cheol Whee Park
Journal:  Clin Exp Nephrol       Date:  2014-04-01       Impact factor: 2.801

Review 3.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

Review 4.  Phosphate Toxicity in CKD: The Killer among Us.

Authors:  Cynthia S Ritter; Eduardo Slatopolsky
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-10       Impact factor: 8.237

Review 5.  Control of phosphate balance by the kidney and intestine.

Authors:  Ichiro Kaneko; Sawako Tatsumi; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2016-11-30       Impact factor: 2.801

6.  [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].

Authors:  G Offermann; K Schaefer; A Schulz; G Delling
Journal:  Klin Wochenschr       Date:  1976-07-01

7.  Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling.

Authors:  Sophie de Seigneux; Marie Courbebaisse; Joseph M Rutkowski; Alexandra Wilhelm-Bals; Marie Metzger; Stellor Nlandu Khodo; Udo Hasler; Hassib Chehade; Eva Dizin; Arezoo Daryadel; Bénedicte Stengel; E Girardin; Dominique Prié; Carsten A Wagner; Philipp E Scherer; Pierre-Yves Martin; Pascal Houillier; Eric Feraille
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

8.  A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism.

Authors:  N Bank; W S Su; H S Aynedjian
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 9.  Metabolic bone disease secondary to renal and intestinal disorders.

Authors:  F P Muldowney
Journal:  Calif Med       Date:  1969-05

10.  On the influence of extracellular fluid volume expansion and of uremia on bicarbonate reabsorption in man.

Authors:  E Slatopolsky; P Hoffsten; M Purkerson; N S Bricker
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.